DOCSLIB.ORG

Pantoprazole Prophylaxis in ICU Patients with High Severity of Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pantoprazole Prophylaxis in ICU Patients with High Severity of Disease Intensive Care Med (2019) 45:609–618 https://doi.org/10.1007/s00134-019-05589-y ORIGINAL Pantoprazole prophylaxis in ICU patients with high severity of disease: a post hoc analysis of the placebo-controlled SUP-ICU trial Søren Marker1,2* , Anders Perner1,2, Jørn Wetterslev2,3, Mette Krag1,2, Theis Lange4,5, Matt P. Wise6, Mark Borthwick7, Stepani Bendel8, Frederik Keus9, Anne Berit Guttormsen10,11, Joerg C. Schefold12, Morten Hylander Møller1,2 and The SUP-ICU investigators © 2019 Springer-Verlag GmbH Germany, part of Springer Nature Abstract Purpose: In the subgroup of patients with Simplifed Acute Physiology Score (SAPS) II > 53 in the Stress Ulcer Prophy- laxis in Intensive Care Unit (SUP-ICU) trial, there was interaction (P 0.049) suggesting increased mortality in patients allocated to pantoprazole as compared with placebo. We aimed to= explore this further. Methods: The SUP-ICU trial allocated acutely admitted adults at risk of gastrointestinal bleeding to pantoprazole vs placebo. In this post hoc study, we repeated all the preplanned analyses of SUP-ICU in patients with baseline SAPS II > 53. Results: A total of 1140 patients had a complete SAPS II > 53 and were included. At 90 days, 272/579 patients (47%) assigned to pantoprazole had died, as compared with 229/558 patients (41%) assigned to placebo [relative risk 1.13; 95% confdence interval (CI) 1.00–1.29]. This was supported by sensitivity analyses adjusted for risk factors and those in the per-protocol population. When accounting for patients with incomplete SAPS II in two additional analyses, the relative risk was 1.08; 95% CI 0.96–1.22 and 1.10; 95% CI 0.97–1.25. This was also observed for the secondary outcome days alive without life support. There were no diferences between the intervention groups in the other secondary outcomes. Conclusions: In this post hoc analysis of patients with high disease severity included in the SUP-ICU trial, we observed higher 90-day mortality and fewer days alive without life support with pantoprazole vs placebo. Some of this may have been explained by missing SAPS II data, but further research is needed to draw frm conclusions. ClinicalTrials.gov: ClinicalTrials.gov No. NCT02467621. Keywords: Stress ulcer prophylaxis, Stress ulceration, Intensive care unit, Gastrointestinal bleeding, All-cause mortality *Correspondence: [email protected] 1 Department of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark Full author information is available at the end of the article 610 Introduction Take‑home message Critically ill patients in the intensive care unit (ICU) are In this post-hoc analysis of a predefned subgroup population in at risk of developing clinically important gastrointestinal the Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) trial, (GI) bleeding due to stress ulcers [1–3]. GI bleeding in we observed higher 90-day mortality and fewer days alive without the use of life support in patients with a complete Simplifed Acute critically ill patients has been suggested to be associated Physiology Score (SAPS) II > 53 points allocated to pantoprazole. with adverse outcomes, including a 2–4-fold increased We found no explanations for these observations in baseline data, risk of death and increased length of ICU stay [3]. To process variables or the other trial outcome measures–however, missing SAPS II data for some patients seem to explain a part of the prevent GI bleeding, stress ulcer prophylaxis is currently observed diference. recommended in international guidelines [4] and acid suppressants are frequently used in ICU patients [2, 5]. In the international Stress Ulcer Prophylaxis in the The SUP‑ICU trial Intensive Care Unit (SUP-ICU) trial, 3350 patients at risk Te SUP-ICU trial was a randomised, multicenter, strati- of GI bleeding were randomised to receive either panto- fed, parallel-group, placebo-controlled, blinded clini- prazole or placebo during the ICU stay [1]. We observed cal trial recruiting 3350 patients (3291 were available no diference between the pantoprazole and placebo for data analyses) at risk for GI bleeding in 33 ICUs in groups in the primary outcome measure—90-day mortal- Denmark, Finland, Norway, Switzerland, the Netherlands ity—but a predefned subgroup analysis suggested higher and UK from 4 January 2016 to 22 October 2017 [7]. Eli- 90-day mortality in the pantoprazole group among gible subjects were patients aged 18 years or older, who patients who had higher baseline disease severity, i.e., were acutely admitted to the ICU and had at least one Simplifed Acute Physiology Score (SAPS) II > 53 points risk factor for clinically important GI bleeding, includ- (test of interaction, p value 0.049) [6, 7]. Tis warrants ing any history of liver disease, any history of or ongoing further investigation, because it may be a chance fnding coagulopathy, shock, or use of anticoagulant agents, renal or driven by baseline imbalance or diferences in with- replacement therapy, or mechanical ventilation expected drawals or follow-up in the subgroup, or missing data for to last > 24 h [1]. SAPS II elements in some patients. We excluded patients with GI bleeding during cur- In this post hoc study of the SUP-ICU trial, we per- rent hospital admission, ongoing daily treatment with formed the full set of preplanned outcome analyses in all acid suppressants, patients who were withdrawn from patients with baseline SAPS II > 53 allocated to pantopra- active treatment or brain dead, had organ transplanta- zole or placebo on all trial outcomes to search for expla- tion during current hospital admission, had peptic ulcer nations to substantiate or refute the suggested harm from confrmed by endoscopy or other method during cur- pantoprazole in the most severely ill. We hypothesised rent hospital admission, had a contraindication to panto- that the increased 90-day mortality observed in patients prazole, were pregnant or where consent for enrolment with SAPS II > 53 allocated to pantoprazole would be could not be obtained. Te full defnitions of the inclu- substantiated in sensitivity analyses and in those of the sion and exclusion criteria are presented in the ESM. remaining outcomes. Patients were randomly assigned to daily intravenous pantoprazole 40 mg or a matching placebo during the Methods ICU stay. Randomisation was stratifed according to the Study oversight presence or absence of hematological malignancy and Tis study is a post hoc analysis of the SUP-ICU trial trial site. Te intervention period lasted until discharge [7]. Te trial protocol, statistical analysis plan and pri- from the ICU to a maximum of 90 days. Te protocol was mary results have been published elsewhere [1, 7, 8]. reinitiated in case of readmissions to trial ICUs within Te SUP-ICU trial was approved by all relevant institu- this period. Apart from the use of stress ulcer prophy- tions prior to randomisation of the frst patient. No addi- laxis, all other parts of patient care were at the discretion tional approvals were required for this study. We have of the clinicians. prepared this manuscript according to the Strengthen- At baseline we collected data on demographics and ing the Reporting of Observational Studies in Epidemi- clinical characteristics. Daily recordings during the ology (STROBE) statement [9], and the flled-in checklist entire admission to the ICU included GI bleeding events, is available in the Electronic Supplementary Material infectious adverse events (pneumonia and Clostridium (ESM). difcile infection) and data on the usage of life support 611 modalities. Time of death was registered for all patients computed from odds ratios [8]. In a sensitivity analysis, at a maximum follow-up of 90 days. Observations for we compared the primary outcome in the per-protocol GI bleeding and infectious adverse events stopped at the population (excluding patients having one or more major time of discharge from the ICU. protocol violations—defnition in ESM), and in the origi- Informed consent was obtained prior to randomisation nally pre-specifed subgroups, defned by the presence from all participants or their legal substitutes according or absence of any history of liver disease, the presence to national legislation. or absence of any history of or ongoing coagulopathy, the type of ICU admission (medical versus surgical), Outcomes the presence or absence of shock and the use or not of Te primary outcome was 90-day mortality. Secondary mechanical ventilation [8]. outcomes were the proportion of patients with clinically In the secondary analyses, we compared all dichoto- important events (a composite outcome of clinically sig- mous outcomes using binary logistic regression analyses nifcant GI bleeding, pneumonia, Clostridium difcile adjusted for stratifcation variables and predefned risk infection and myocardial ischemia), clinically important factors at baseline (age, type of admission (medical, elec- GI bleeding, infectious adverse events (pneumonia or tive surgery or emergency surgery) and the Sepsis-related Clostridium difcile infection) and serious adverse reac- Organ Failure Assessment (SOFA) score (Table S8 in the tions (SARs) and the percentage of days alive without the ESM) assessed in the 24 h before randomisation). We use of life support (mechanical ventilation, renal replace- analysed percentages of days alive without life support in ment therapy or inotropes/vasopressor) [1]. the 90-day period by use of the van Elteren test (adjusted for site only), as the assumptions
Load more

Recommended publications
  • Sepsis 6/08/2012
    Version 2.3 Sepsis 6/08/2012 Introduction • Common ED presentation. • 2% of hospitalisations • Significant hospital mortality if shock: 23-46%. Role of Emergency Physicians • ~33% patients with sepsis admitted through the ED. • “Golden hour" may be critical concept • ED Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group 2004 EBM guidelines (updated in January 2008) Definition of Sepsis Syndromes and Organ Failure Sepsis = Systemic inflammatory response syndrome (SIRS) during an infection. Need ≥2 from: • Temperature > 38°C or < 36°C • HR >90bpm (>160 infants, >150 children) • Respiratory Rate (RR) > 20 breaths/min or PaCO 2<32mmHg • WBC>12x10 9/L or <4x10 9/L (or >10% immature bands) Infection without SIRS = Suspected infection without SIRS criteria. Severe sepsis = Sepsis and organ dysfunction or hypoperfusion: • Neurologic: New altered mental status; • Hematologic: plt<100x10 6/L; Coagulopathies i.e INR >1.5; APTT >60 secs • Renal: Cr>44.2µmol/L w/o CRF; or ↑11.1µmol/L; acute oliguria (<0.5mL/kg/hr) for ≥2hr despite fluid resuscitation • Pulmonary: RR>20; SaO2<90% or <94%+O2/mech vent; PaO 2/FIO 2<300 • GI: Ileus; absent bowel sounds; hyperbilirubinemia (total bilirubin >70mmol/L) • Cardiovascular: Septic shock Septic shock. Sepsis and refractory hypotension - BP sys <90 mmHg (<75mmHg child, <65mmHg infants), MAP<65mmHg, or BP sys ↓40mmHg from baseline; unresponsive to fluid (20-40ml/kg) Assessment History – risk factors (age, M>F, immune status, EtOH dependence, malignancy, indwelling catheter, prosthetics), contacts, likely source. Premorbid state/medical history. Examination – Vitals, signs of SIRS/sepsis as above, focal signs of infection Investigations Beside: Urinalysis (& send for MC&S), BSL, ABG + serial lactate (for 2h clearance) - Blood: FBC ( ↓Hb, ↓Hct, ↑↓ WCC+diff, ↓plt), UEC ( ↑Cr, ↓HCO 3 ), ↑LFT, gluc, ↑coags, ± D-dimers & FDPs, Procalcitonin, CRP, CK, cultures Imaging: CXR, ±AXR, CT as indicated.
    [Show full text]
  • Infection Related Catheter Complications in Patients
    Louis et al. BMC Infectious Diseases (2021) 21:534 https://doi.org/10.1186/s12879-021-06197-2 RESEARCH Open Access Infection related catheter complications in patients undergoing prone positioning for acute respiratory distress syndrome: an exposed/unexposed study Guillaume Louis1* , Thibaut Belveyre1†, Audrey Jacquot2†, Hélène Hochard3, Nejla Aissa4, Antoine Kimmoun2, Christophe Goetz5, Bruno Levy2 and Emmanuel Novy1 Abstract Background: Prone positioning (PP) is a standard of care for patients with moderate–severe acute respiratory distress syndrome (ARDS). While adverse events associated with PP are well-documented in the literature, research examining the effect of PP on the risk of infectious complications of intravascular catheters is lacking. Method: All consecutive ARDS patients treated with PP were recruited retrospectively over a two-year period and formed the exposed group. Intensive care unit (ICU) patients during the same period without ARDS for whom PP was not conducted but who had an equivalent disease severity were matched 1:1 to the exposed group based on age, sex, centre, length of ICU stay and SAPS II (unexposed group). Infection-related catheter complications were defined by a composite criterion, including catheter tip colonization or intravascular catheter-related infection. Results: A total of 101 exposed patients were included in the study. Most had direct ARDS (pneumonia). The median [Q1–Q3] PP session number was 2 [1–4]. These patients were matched with 101 unexposed patients. The mortality rates of the exposed and unexposed groups were 31 and 30%, respectively. The incidence of the composite criterion was 14.2/1000 in the exposed group compared with 8.2/1000 days in the control group (p = 0.09).
    [Show full text]
  • The Association Between Four Scoring Systems and 30-Day Mortality Among Intensive Care Patients with Sepsis
    www.nature.com/scientificreports OPEN The association between four scoring systems and 30‑day mortality among intensive care patients with sepsis: a cohort study Tianyang Hu 1,4, Huajie Lv2,4 & Youfan Jiang3* Several commonly used scoring systems (SOFA, SAPS II, LODS, and SIRS) are currently lacking large sample data to confrm the predictive value of 30‑day mortality from sepsis, and their clinical net benefts of predicting mortality are still inconclusive. The baseline data, LODS score, SAPS II score, SIRS score, SOFA score, and 30‑day prognosis of patients who met the diagnostic criteria of sepsis were retrieved from the Medical Information Mart for Intensive Care III (MIMIC‑III) intensive care unit (ICU) database. Receiver operating characteristic (ROC) curves and comparisons between the areas under the ROC curves (AUC) were conducted. Decision curve analysis (DCA) was performed to determine the net benefts between the four scoring systems and 30‑day mortality of sepsis. For all cases in the cohort study, the AUC of LODS, SAPS II, SIRS, SOFA were 0.733, 0.787, 0.597, and 0.688, respectively. The diferences between the scoring systems were statistically signifcant (all P‑values < 0.0001), and stratifed analyses (the elderly and non‑elderly) also showed the superiority of SAPS II among the four systems. According to the DCA, the net beneft ranges in descending order were SAPS II, LODS, SOFA, and SIRS. For stratifed analyses of the elderly or non‑elderly groups, the results also showed that SAPS II had the most net beneft. Among the four commonly used scoring systems, the SAPS II score has the highest predictive value for 30‑day mortality from sepsis, which is better than LODS, SIRS, and SOFA.
    [Show full text]
  • Secondary Stroke in Patients with Polytrauma and Traumatic Brain Injury Treated in an Intensive Care Unit, Karlovac General Hosp
    Injury, Int. J. Care Injured 46S (2015) S31–S35 Contents lists available at ScienceDirect Injury jo urnal homepage: www.elsevier.com/locate/injury Secondary stroke in patients with polytrauma and traumatic brain injury treated in an Intensive Care Unit, Karlovac General Hospital, Croatia a b a a c a,d, M. Belavic´ , E. Jancˇic´ , P. Misˇkovic´ , A. Brozovic´-Krijan , B. Bakota , J. Zˇunic´ * a ˇ Department of Anaesthesiology, Reanimatology and Intensive Medicine, Karlovac General Hospital, Andrije Stampara 3, 47000 Karlovac, Croatia b ˇ Department of Neurology, Karlovac General Hospital, Andrije Stampara 3, 47000 Karlovac, Croatia c Orthopaedics and Traumatology Department, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland d Karlovac University of Applied Sciences, Trg Josipa Jurja Strossmayera 9, 47000 Karlovac, Croatia A R T I C L E I N F O A B S T R A C T Keywords: Traumatic brain injury (TBI) is divided into primary and secondary brain injury. Primary brain injury Traumatic brain injury occurs at the time of injury and is the direct consequence of kinetic energy acting on the brain tissue. Intracranial pressure Secondary brain injury occurs several hours or days after primary brain injury and is the result of factors Cerebral including shock, systemic hypotension, hypoxia, hypothermia or hyperthermia, intracranial hyperten- Perfusion sion, cerebral oedema, intracranial bleeding or inflammation. The aim of this retrospective analysis of a Mean arterial pressure prospective database was to determine the prevalence of secondary stroke and stroke-related mortality, Secondary Stroke causes of secondary stroke, treatment and length of stay in the ICU and hospital.
    [Show full text]
  • Have Severity Scores a Place in Predicting Septic Complications in ICU Multiple Trauma Patients?
    The Journal of Critical Care Medicine 2016;2(3):107-108 EDITORIAL DOI: 10.1515/jccm-2016-0023 Have Severity Scores a Place in Predicting Septic Complications in ICU Multiple Trauma Patients? Daniela Ionescu Department of Anesthesia and Intensive Care I, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania; Outcome Research Consortium, Cleveland, USA Risk assessment in ICU critically-ill patients is of tre- Tranca et al. reported a study which aimed at iden- mendous importance for optimizing patients’ clinical tifying the most accurate method or score to predict management, medical and human resource allocation the risk of septic complications in multiple trauma pa- and supporting medical cost distribution and contain- tients [14]. The study also investigated if severity scores ment. may be used for this purpose and if there were highly The problem of predicting complications and mor- predictive cut-off values for septic complications in tality in ICU patients, although not new, is of genuine multiple trauma patients. The authors found that both concern and much effort has been made to detect the functional severity and specific scores might be used most reliable parameters and scores. Numerous at- to predict risks of septic complications in multiple tempts have been made to use clinical and laboratory trauma patients and describe cut-off values for these findings integrated into different algorithms or to in- scores which are most reliable in predicting infectious corporate these parameters into easy to use composite complications in this category of patients. Thus a SOFA severity scores which would be applicable in various score >4 and an APACHE II ≥11 were predictive of centers.
    [Show full text]
  • Validation of APACHE II, APACHE III and SAPS II Scores in In-Hospital
    Czajka et al. BMC Anesthesiology (2020) 20:296 https://doi.org/10.1186/s12871-020-01203-7 RESEARCH ARTICLE Open Access Validation of APACHE II, APACHE III and SAPS II scores in in-hospital and one year mortality prediction in a mixed intensive care unit in Poland: a cohort study Szymon Czajka1* , Katarzyna Ziębińska2, Konstanty Marczenko2, Barbara Posmyk2, Anna J. Szczepańska1 and Łukasz J. Krzych1 Abstract Background: There are several scores used for in-hospital mortality prediction in critical illness. Their application in a local scenario requires validation to ensure appropriate diagnostic accuracy. Moreover, their use in assessing post- discharge mortality in intensive care unit (ICU) survivors has not been extensively studied. We aimed to validate APACHE II, APACHE III and SAPS II scores in short- and long-term mortality prediction in a mixed adult ICU in Poland. APACHE II, APACHE III and SAPS II scores, with corresponding predicted mortality ratios, were calculated for 303 consecutive patients admitted to a 10-bed ICU in 2016. Short-term (in-hospital) and long-term (12-month post- discharge) mortality was assessed. Results: Median APACHE II, APACHE III and SAPS II scores were 19 (IQR 12–24), 67 (36.5–88) and 44 (27–56) points, with corresponding in-hospital mortality ratios of 25.8% (IQR 12.1–46.0), 18.5% (IQR 3.8–41.8) and 34.8% (IQR 7.9–59.8). Observed in-hospital mortality was 35.6%. Moreover, 12-month post-discharge mortality reached 17.4%. All the scores predicted in-hospital mortality (p < 0.05): APACHE II (AUC = 0.78; 95%CI 0.73–0.83), APACHE III (AUC = 0.79; 95%CI 0.74– 0.84) and SAPS II (AUC = 0.79; 95%CI 0.74–0.84); as well as mortality after hospital discharge (p < 0.05): APACHE II (AUC = 0.71; 95%CI 0.64–0.78), APACHE III (AUC = 0.72; 95%CI 0.65–0.78) and SAPS II (AUC = 0.69; 95%CI 0.62–0.76), with no statistically significant difference between the scores (p > 0.05).
    [Show full text]
  • Early Goal-Directed Therapy in the Management of Severe Sepsis Or
    Zhang et al. BMC Medicine (2015) 13:71 DOI 10.1186/s12916-015-0312-9 RESEARCH ARTICLE Open Access Early goal-directed therapy in the management of severe sepsis or septic shock in adults: a meta-analysis of randomized controlled trials Ling Zhang1, Guijun Zhu2, Li Han3 and Ping Fu4* Abstract Background: The Surviving Sepsis Campaign guidelines have proposed early goal-directed therapy (EGDT) as a key strategy to decrease mortality among patients with severe sepsis or septic shock. However, its effectiveness is uncertain. Methods: We searched for relevant studies in Medline, Embase, the Cochrane Library, Google Scholar, and a Chinese database (SinoMed), as well as relevant references from January 1966 to October 2014. We performed a systematic review and meta-analysis of all eligible randomized controlled trials (RCTs) of EGDT for patients with severe sepsis or septic shock. The primary outcome was mortality; secondary outcomes were length of ICU and in-hospital stay, mechanical ventilation support, vasopressor and inotropic agents support, fluid administration, and red cell transfusion. We pooled relative risks (RRs) or weighted mean differences (MDs) with 95% confidence intervals (95% CI) using Review Manager 5.2. Results: We included 10 RCTs from 2001 to 2014 involving 4,157 patients. Pooled analyses of all studies showed no significant difference in mortality between the EGDT and the control group (RR 0.91, 95% CI: 0.79 to 1.04, P = 0.17), with substantial heterogeneity (χ2 = 23.65, I2 = 58%). In the subgroup analysis, standard EGDT, but not modified EGDT, was associated with lower mortality rate in comparison with the usual care group (RR 0.84, 95% CI: 0.72 to 0.98, P = 0.03).
    [Show full text]
  • Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
    The New England Journal of Medicine EARLY GOAL-DIRECTED THERAPY IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK EMANUEL RIVERS, M.D., M.P.H., BRYANT NGUYEN, M.D., SUZANNE HAVSTAD, M.A., JULIE RESSLER, B.S., ALEXANDRIA MUZZIN, B.S., BERNHARD KNOBLICH, M.D., EDWARD PETERSON, PH.D., AND MICHAEL TOMLANOVICH, M.D., FOR THE EARLY GOAL-DIRECTED THERAPY COLLABORATIVE GROUP* ABSTRACT HE systemic inflammatory response syn- Background Goal-directed therapy has been used drome can be self-limited or can progress to for severe sepsis and septic shock in the intensive care severe sepsis and septic shock.1 Along this unit. This approach involves adjustments of cardiac continuum, circulatory abnormalities (intra- preload, afterload, and contractility to balance oxygen Tvascular volume depletion, peripheral vasodilatation, delivery with oxygen demand. The purpose of this myocardial depression, and increased metabolism) lead study was to evaluate the efficacy of early goal-direct- to an imbalance between systemic oxygen delivery and ed therapy before admission to the intensive care unit. oxygen demand, resulting in global tissue hypoxia or Methods We randomly assigned patients who ar- shock.2 An indicator of serious illness, global tissue rived at an urban emergency department with severe sepsis or septic shock to receive either six hours of hypoxia is a key development preceding multiorgan 2 early goal-directed therapy or standard therapy (as a failure and death. The transition to serious illness oc- control) before admission to the intensive care unit. curs during the critical “golden hours,” when defin- Clinicians who subsequently assumed the care of the itive recognition and treatment provide maximal ben- patients were blinded to the treatment assignment.
    [Show full text]
  • Designing Optimal Mortality Risk Prediction Scores That Preserve
    1 Designing Optimal Mortality Risk Prediction Scores that Preserve Clinical Knowledge Natalia M. Arzeno (1), Karla A. Lawson (2), Sarah V. Duzinski (2), Haris Vikalo (1) (1) Department of Electrical and Computer Engineering, The University of Texas at Austin, (2) Trauma Services, Dell Children’s Medical Center of Central Texas Email: [email protected], [email protected] Abstract Many in-hospital mortality risk prediction scores dichotomize predictive variables to simplify the score calculation. However, hard thresholding in these additive stepwise scores of the form “add x points if variable v is above/below threshold t” may lead to critical failures. In this paper, we seek to develop risk prediction scores that preserve clinical knowledge embedded in features and structure of the existing additive stepwise scores while addressing limitations caused by variable dichotomization. To this end, we propose a novel score structure that relies on a transformation of predictive variables by means of nonlinear logistic functions facilitating smooth differentiation between critical and normal values of the variables. We develop an optimization framework for inferring parameters of the logistic functions for a given patient population via cyclic block coordinate descent. The parameters may readily be updated as the patient population and standards of care evolve. We tested the proposed methodology on two arXiv:1411.5086v2 [stat.ML] 29 Apr 2015 populations: (1) brain trauma patients admitted to the intensive care unit of the Dell Children’s Medical Center of Central Texas between 2007 and 2012, and (2) adult ICU patient data from the MIMIC II database. The results are compared with those obtained by the widely used PRISM III and SOFA scores.
    [Show full text]
  • Characteristics and Outcomes of Patients Infected with Ncov19 Ncov19
    ARTIGO ORIGINAL Gustavo A. Plotnikow1,15 , Amelia Matesa2,15, Juan M. Nadur3,15, Marcelo Alonso4,15, Ignacio Características y resultados de los pacientes Nuñez I5,15, Gabriel Vergara6,15, Maria J. Alfageme7,15, Agustin Vitale8,15, Marco Gil9,15, infectados con nCoV19 con requerimiento de Valeria Kinzler10,15, Marianela Melia11,15, Florencia Pugliese12,15, Mariana Donnianni13,15, Joana ventilación mecánica invasiva en la Argentina Pochettino14,15, Ignacio Brozzi15, Jose Luis Scapellato1, por el Grupo Argentino Telegram Characteristics and outcomes of patients infected with nCoV19 nCoV19. requiring invasive mechanical ventilation in Argentina 1. Sanatorio Anchorena - Buenos Aires, RESUMEN SAPS II de 43, un índice de Charlson de Argentina. 3. El modo ventilatorio inicial fue volume 2. Clínica Basilea - Buenos Aires, Argentina. 3. Clínica de Internación Aguda en Rehabilitación control - continuous mandatory ventilation y Cirugía - Buenos Aires, Argentina. Objetivo: El coronavirus ha emergido con volumen corriente menor a 8mL/ 4. Clínica Pasteur - Neuquén, Argentina. este año como causa de neumonía viral. kg en el 100% de los casos, con una 5. Hospital Evita Pueblo - Buenos Aires, Una de las principales características es su mediana de presión positiva al final de la Argentina. rápida transmisión y su potencial severidad. espiración de 10,5cmH2O. A la fecha de 6. Sanatorio Femechaco de la Comunidad - El objetivo de este estudio de serie de Chaco, Argentina. cierre del estudio, 29 pacientes fallecieron, 7. Hospital San Miguel Arcángel - Buenos Aires, casos es describir las características clínicas 8 alcanzaron el alta, y 10 pacientes Argentina. de los pacientes con confirmación de continúan internados al cierre del estudio. 8.
    [Show full text]
  • Outcome of Severe Lactic Acidosis Associated with Metformin Accumulation Sigrun Friesecke1*, Peter Abel1, Markus Roser2, Stephan B Felix1, Soeren Runge3
    Friesecke et al. Critical Care 2010, 14:R226 http://ccforum.com/content/14/6/R226 RESEARCH Open Access Outcome of severe lactic acidosis associated with metformin accumulation Sigrun Friesecke1*, Peter Abel1, Markus Roser2, Stephan B Felix1, Soeren Runge3 Abstract Introduction: Metformin associated lactic acidosis (MALA) may complicate metformin therapy, particularly if metformin accumulates due to renal dysfunction. Profound lactic acidosis (LA) generally predicts poor outcome. We aimed to determine if MALA differs in outcome from LA of other origin (LAOO). Methods: We conducted a retrospective analysis of all patients admitted with LA to our medical ICU of a tertiary referral center during a 5-year period. MALA patients and LAOO patients were compared with respect to parameters of acid-base balance, serum creatinine, hospital outcome, Simplified Acute Physiology Score II (SAPS II) and Sequential Organ Failure Assessment (SOFA) score, using Pearson’s Chi-square or the Mann-Whitney U-test. Results: Of 197 patients admitted with LA, 10 had been diagnosed with MALA. With MALA, median arterial blood pH was significantly lower (6.78 [range 6.5 to 6.94]) and serum lactate significantly higher (18.7 ± 5.3 mmol/L) than with LAOO (pH 7.20 [range 6.46 to 7.35], mean serum lactate 11.2 ± 6.1 mmol/L). Overall mortality, however, was comparable (MALA 50%, LAOO 74%). Furthermore, survival of patients with arterial blood pH < 7.00 (N = 41) was significantly better (50% vs. 0%) if MALA (N = 10) was the underlying condition compared to LAOO (N = 31). Conclusions: Compared to similarly severe lactic acidosis of other origin, the prognosis of MALA is significantly better.
    [Show full text]
  • Hidden Markov Chain Modeling and Analysis for ICU Mortality Prediction
    Abstract ID#: 3147 Category: Health Sciences Undergraduate/Graduate: PhD CHF-AR-HMM and Analysis for Post-ICU Mortality Prediction Yilin Yin, Chun-An Chou Department of Mechanical & Industrial Engineering, Northeastern University Overlook Modeling: Conduct Autoregressive hidden Markov model (AR-HMM) The intensive care unit (ICU) mortality prediction q The post-ICU dynamic risk (mortality) prediction is on demand by patients for timely decision making and consecutive care q Our goal is to predict the mortality within certain days (e.g., 5-10 days since admission) with the last 24-hour physiology data by improving the existing scoring system State-of-the-art Scoring System q Risk scores converted from irregular time-series body vitals and laboratory test data are delivered for predicting mortality q In this case, Simplified Acute Physiology Score (SAPS) II [1] designed for mortality prediction is considered Fig 3. Methodology workflow and CHF-AR-HMM mixture model. Challenges q Risk scoring systems are not capable of capturing the patient’s severity level in a dynamic manner q Current cumulative hazard Markov model method relies on the prior probability, which is highly biased Methodology q We use the mixture model CHF-AR_HMM as combination of autoregressive Hidden Markov model (AR-HMM) [2] with cumulative hazard function (CHF) [3] to discover the latent states (survival or death) dynamic on the aggregated data from the risk scoring system for each patient Data Processing q PhysioNet ICU Challenge 2012 MIMIC II [4] is used for model validation, including first 48-hour ICU monitoring (12 physiology variables and other patient attributes), laboratory tests data since ICU admission from 12000 patients, the demographic and mortality outcome information.
    [Show full text]